Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate

被引：28
|
作者：
Rousselot, P [1 ]
Larghero, J
Raffoux, E
Calvo, F
Tulliez, M
Giraudier, S
Rybojad, M
机构：
[1] Hop St Louis, Serv Clin Malad Sang, Paris, France
[2] Hop St Louis, Ctr Invest Clin, Paris, France
[3] Hop Henri Mondor, Hematol Lab, F-94010 Creteil, France
[4] Hop St Louis, Serv Dermatol, F-75475 Paris, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2003年 / 120卷 / 06期
关键词：
imatinib mesylate; c-Kit; chronic myelogenous leukaemia; photosensitivity; depigmentation;
D O I：
10.1046/j.1365-2141.2003.04208_3.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1091 / 1092
页数：2
相关论文
共 50 条
  • [21] Resistance to imatinib mesylate in chronic myeloid leukaemia
    Melo, Junia V.
    Chuah, Charles
    CANCER LETTERS, 2007, 249 (02) : 121 - 132
  • [22] Imatinib mesylate discontinuation in patients with chronic myelogenous leukaemia in complete molecular remission for more than two years.
    Rousselot, P
    Huguet, F
    Cayuela, JM
    Maarek, O
    Marit, G
    Gluckman, E
    Reiffers, J
    Mahon, FX
    BLOOD, 2005, 106 (11) : 321A - 321A
  • [23] Imatinib mesylate therapy in patients with chronic myeloid leukaemia previously treated with autologous stem cell transplantation
    Cortés, M
    Sureda, A
    Martino, R
    Aventin, A
    Nomdedeu, J
    Briones, J
    Valcárcel, D
    Brunet, S
    Sierra, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S151 - S151
  • [24] Pharmacokinetic variability of imatinib mesylate in Indian patients of chronic myeloid leukaemia
    Mohan, P.
    Uppal, R.
    Chandgude, S.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S105 - S105
  • [25] Imatinib mesylate -: A new pill for chronic myelogenous leukemia
    Parmar, KK
    King, RS
    CANCER PRACTICE, 2001, 9 (05) : 263 - 265
  • [26] Impact of Imatinib on the Fertility of Male Patients with Chronic Myelogenous Leukaemia in the Chronic Phase
    Xiaohui Chang
    Lin Zhou
    Xiaoxia Chen
    Baoli Xu
    Yubin Cheng
    Shujun Sun
    Meiyun Fang
    Yang Xiang
    Targeted Oncology, 2017, 12 : 827 - 832
  • [27] Impact of Imatinib on the Fertility of Male Patients with Chronic Myelogenous Leukaemia in the Chronic Phase
    Chang, Xiaohui
    Zhou, Lin
    Chen, Xiaoxia
    Xu, Baoli
    Cheng, Yubin
    Sun, Shujun
    Fang, Meiyun
    Xiang, Yang
    TARGETED ONCOLOGY, 2017, 12 (06) : 827 - 832
  • [28] Imatinib mesylate before allogeneic haematopoietic cell transplantation in chronic myelogenous leukaemia:: impact on transplant outcome?
    Bornhäuser, M
    Kröger, N
    Schwerdtfeger, R
    Schäfer-Eckart, K
    Sayer, H
    Scheid, C
    Stelljes, M
    Kienast, J
    Mundhenk, P
    Fruehauf, S
    Kiehl, M
    Wandt, H
    Theuser, C
    Ehninger, G
    Zander, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S67 - S68
  • [29] Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa
    Marin, D
    Marktel, S
    Bua, M
    Szydlo, RM
    Franceschino, A
    Nathan, I
    Foot, N
    Crawley, C
    Nakorn, TN
    Olavarria, E
    Lennard, A
    Neylon, A
    O'Brien, SG
    Goldman, JM
    Apperley, JF
    LEUKEMIA, 2003, 17 (08) : 1448 - 1453
  • [30] Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa
    D Marin
    S Marktel
    M Bua
    R M Szydlo
    A Franceschino
    I Nathan
    N Foot
    C Crawley
    T Na Nakorn
    E Olavarria
    A Lennard
    A Neylon
    S G O'Brien
    J M Goldman
    J F Apperley
    Leukemia, 2003, 17 : 1448 - 1453
12345